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Incidence of Surrogacy in the USA and Israel and Implications on Women's Health 
A Quantitative Comparison 
 
ABSTRACT 
 
Purpose. Gestational surrogacy (GS) has been researched in multiple qualitative studies. In 
sharp contrast, quantitative aspects of the practice are conspicuously understudied. The present 
article aims to assess and compare the incidence of GS in the USA and Israel, two industrialized 
countries that have maintained active, formally regulated surrogacy practice, for over two 
decades.  
Method. The article is a secondary analysis of official GS figures published by the USA and 
Israel. Each dataset is analyzed vis-à-vis the respective country's population, adult population 
and number of deliveries and infants born, so as to devise local Incidence Scores. These scores 
are the basis for an inter-country comparison. 
Results. The incidence of GS is rising in both countries. Though USA surrogates are contracted 
by both local and international, heterosexual and gay, partnered and single intended parents, the 
relative incidence of GS is lower in the USA than in Israel, at a ratio of 2:3, even though in Israel 
only local heterosexual couples and single women may contract a gestational surrogate.  
Conclusion. GS emerges as reflective of its social surrounding, with the ratios between the 
countries' GS incidence resembling the ratios between their respective fertility rates. The paper 
ends with considering two risks facing gestational surrogates: the risk of not conceiving and not 
being paid, which is the outcome of most GS cycles, and the risk of carrying a multiple 
pregnancy, which is extremely prevalent in GS pregnancies, and sustaining the short- and long-
term health consequences that are likely to accompany it. 
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INTRODUCTION 
 
Over the past two decades, gestational surrogacy has gained acceptance and has proliferated in 
growing social circles. Men and women from industrialized and developing countries, partnered 
and singles, heterosexual, homosexual and others are engaged in commercial surrogacy as 
gestational surrogates, intended parents, travel agents, brokers and clinicians. Still, very little is 
known about the scope of the practice and its incidence. In this article, we aim to provide a 
preliminary comparative assessment of the practice, as it takes place in the USA and Israel.  
 
Social scientists have looked at a broad range of aspects related to GS, including legal and 
ethical aspects [1], [2] and [3]; the concept of reproductive justice as it is and as it should be 
enacted in various domains of surrogacy [4]; legislation-guided movements of people from one 
surrogacy hub to another in search of cross border reproductive assistance [3], [5], [6]. 
Gestational surrogacy was also discussed as a vantage point for the exploration of broader 
phenomena like the commodification [7]; fragmentation and globalization of reproduction [8], 
[9], [10] in the age of late capitalism [11]; and racialized aspects of the global order [12], [13], 
[14]. Even more generally, surrogacy was discussed as an instance of various sorts of border 
crossing [15], [16], [17]. LGBTQ use of surrogacy was analyzed as a meeting point of queer 
reproductions, stratified reproduction and reproductive justice [18]. On a different scale, 
surrogacy was applied as a prism for the study of the situated significance of normal pregnancy 
in the societies in which it was practised [19], [20]. 
 
Studies at a micro-social level have looked at the embodied experience of surrogates [11], [21] 
and the implications on people surrounding them [22], as well as on prevailing kinship 
perceptions [23]. Surrogates' negotiation of their roles [22] and their lived experiences were 
thoroughly considered within the context of specific local surrogacy industries, e.g., in India 
[14], [9], in the USA [24], [25] and in Israel [21]. The significance of payment has also been 
elucidated [22]. Some feminist scholars expressed highly critical views of GS as exploitative and have 
tried to advance a ban on commercial surrogacy [26], [27], [28]. 
 
In edited collections [1], [17], and review articles, e.g. [29],  as well as in books and journal 
papers, like the ones referenced here, these and other researchers have looked across various 
geographical settings, spanning from Thailand and Laos [5], India [14], [9], [30], [31], [4], [32], 
[16] and Turkey [33], to the UK [34], the USA [18], [35], [25], [36]–[38], Germany, Switzerland 
[39], and Israel [19], [40].  
 
Against this scholarly plethora, the scarcity of quantitative studies is glaring. In this paper, we 
hope to supplement the qualitative understandings by a quantitative analysis of the scope of 
commercial surrogacy in two practice-intensive settings, Israel and the USA. The analysis is 
based on raw data published by the official authorities in each country. The decision to compare 
these particular countries, despite their evidently different sizes, was guided by several 
considerations: First, both countries are among the few industrialized countries that allow and 
formally regulate commercial surrogacy. Second, the two have maintained GS practice for over 
20 years. Third, in both the USA and Israel, surrogacy is a highly active field, as detailed in the 
following sections. At the same time, each of the countries is situated differently in the global 
surrogacy landscape: Israel is on the 'outsourcing' side, with numerous Israelis travelling abroad 
for GS, whereas the US is on the provider's side, serving a substantial international clientele of 
intended parents (IP) of various citizenships, personal statuses and sexual orientations. Our 
quantitative assessment seeks to situate the relative magnitude of each of the local GS practices 
within its context, and then probe possible implications on local women's health and wellbeing. 
 
Background: The Research Fields  
Israel is a highly familial society. Though comparable to OECD countries in terms of life 
expectancy, women’s education and labour market participation, more Israelis marry, they do so 
at an earlier age, have roughly twice as many children and divorce less frequently than their 
foreign counterparts [41]. One aspect of this familial profile is an unparalleled state funding of 
fertility treatments including In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection 
(ICSI) that are provided nearly free of charge, to every Israeli woman, without screening, until 
the age of 45 and the birth of two live children with her current partner. In the sphere of 
surrogacy, Israel was the world’s first country to legislate a dedicated primary law (in 1996) for 
GS regulation. Since then, a state committee screens applicants seeking to become either 
gestational surrogates or IP. Eligibility to domestic surrogacy is restricted to heterosexual 
couples, with single women gaining access in 2018. The procedure is privately funded and 
amounts to $50,000-60,000. Gay men, who wish to found families, travel abroad for cross border 
ova donations and GS. In recent years, a growing number of Israeli heterosexual couples, also 
prefer to conduct surrogacy abroad, primarily, due to the faster pace of the process and the 
distance from the surrogate, which some IP consider an advantage [42]. Countries of destination 
vary according to changes in legislation, currently concentrating in Georgia, Albania and the 
USA [43].  
 
In the USA, the legal status of surrogacy varies greatly from one state to another. Some states 
apply explicitly friendly regulations (e.g., California, Connecticut, Massachusetts) and treat GS 
contracts as enforceable, whereas others (e.g., New York, Michigan, Utah) restrict the practice 
and under some circumstances, may criminalize GS contracts [44]. American men and women 
also travel abroad for surrogacy, mostly, in order to moderate the high expenditure that the 
practice entails in the USA. Like their Israeli counterparts, USA resident IP have also faced 
increasingly restrictive policies in numerous developing countries that have banned the 
procedure to foreigners or gay IP. For many of these potential IP, the USA has become the more 
realistic and accessible site for surrogacy assisted family formation. At the same time, the USA 
has been an international hub of commercial surrogacy, serving a wide international range of IP. 
This international standing has become more salient in the past decade [37], possibly due to the 
growing restrictions on foreign and gay surrogacy in South Asian countries.  
 
METHODS 
The present article is a secondary analysis of official U.S. and Israeli GS data. Extrapolating 
from the raw figures, we devised a series of Incidence Scores for each of the settings.  
 
Israel. Ministry of Health data was published by the Knesseth (Parliament) Centre for Research 
and Information on October 2018 [42]. The document provides comprehensive figures regarding 
surrogacy practice endorsed by Israelis, both domestically and abroad. The data on domestic 
surrogacy is based on birth reports and monitors deliveries and live-born infants. The number of 
cross border surrogacy (CBS) deliveries is approximated by applications for DNA testing, a state 
prerequisite for the admission of CBS infants into Israel. This dataset on CBS does not include 
the number of infants born.  
 
The USA. For the USA, we rely on two articles reporting CDC surrogacy figures, primarily for 
the years 2009-2013 and 2010-2014 [36]–[38]. These figures provide a comprehensive depiction 
of the USA GS scene, counting all GS cycles in which at least one embryo was transferred. USA 
citizens who travel abroad for the procedure are not included. Much as we searched, we did not 
find any estimates of the scope of CBS carried out by USA resident IP.  
 
The comparison looks at the five years for which we have figures for both countries: 2010-2014. 
It is based on several Incidence Scores that measure surrogacy figures vis-à-vis relevant 
populations. Given the difference in age distribution of the general population in the two 
countries, which represents Israel's higher fertility rates, we also calculated, in addition to 
Populations Scores, also Adult Population Scores, which weigh the number of GS deliveries and 
infants vis-à-vis each country’s adult population. As our focus in this study is primarily on the 
local women who serve as gestational surrogates, and as we have no data regarding cross border 
GS deliveries and Infants born to USA resident IP, we focus our inquiry on domestic GS in both 
settings. In light of the scope of the scrutinized phenomenon and the relative scarcity of GS as an 
epidemiological phenomenon, our scores are calculated per million population, rather than the 
customary figure per thousand. 
 
RESULTS 
Israel. Between the years 1998 and 2017, 823 infants were born in Israel following 666 domestic 
GS births. Starting from 11 applications submitted to the National Surrogacy Committee in the 
year 1996, when the Embryo Carrying Agreements Law was ratified, the annual average has 
quintupled from 21 applications in the first six years (1996-2001) to 107 in recent years (2012-
2017; authors’ calculations from Figure 1 [42]). The average number of deliveries for the 
scrutinized period (2010-2014), was 52 a year (see Table 1 authors’ calculations from Table 1 
[42]). Directing our look at the number of infants born in Israel following GS, we learn that 64 
infants were born on average every year, following GS in Israel and that on average the Baby / 
Delivery ratio in domestic surrogacy deliveries amounted to 1.24. Figures provided by Israel's 
Central Bureau of Statistics (CBS) reveal an even steeper increase, from an annual average of 27 
infants in 2005-2011, to 221 in recent years (2012-2017; authors’ calculations from Tables 2 and 
3 [42]).  
 
Table 1: GS Deliveries and Infants Born to Israelis in Israel and Abroad (2010-2014) 
from Tables 1, 2 and 3 [42] 
 Domestic Surrogacy Cross Border Surrogacy 
Performed by Israeli IP 
 
Year  
GS deliveries 
in Israel 
GS infants 
born in Israel 
Infant / 
Delivery 
CBS 
Deliveries  
Assessed CBS 
infants*  
2010 46 56 1.22 49 61 
2011 49 68 1.39 93 115 
2012 41 49 1.20 128 159 
2013 58 72 1.24 169 210 
2014 65 76 1.17 232 288 
Total  259 321  671       833 
    All Deliveries (N): 930                    All Infants: 1,154 
Annual 
Average  
521 64 1.24 134        167 
    All Deliveries (An. Av.): 186            All Infants (An. Av.): 231 
Av. Ann. 
Growth 
7.15%   36.48%  
*applying the average Israeli domestic Baby / Delivery ratio of 1.24, which is, according to informal assessment of 
local gay surrogacy parents, a conservative assumption. 
 
The table thus shows that the bulk of GS deliveries, in recent years, take place abroad. It also 
captures the substantial proportion of multiple births. In order to gain a relative estimate of these 
figures, we weighed them against the local population. As elucidated above, our focus is on 
domestic GS in both settings. Table 2 presents the emerging picture: 
 
Table 2: Israeli GS Delivery and Infant Scores (2010-2014) 
Authors’ calculations 
 
IL Score Score Description 
 
Score Value 
Domestic GS Delivery Score An. Av. Domestic IL GS Deliveries 
/ M IL Pop. 
52 / 7.92 = 6.58 
Domestic GS Infants Score An. Av. GS Infants born in Il / M 
IL Pop. 
64 / 7.9 = 8.1 
Domestic GS Delivery Adult Score An. Av. Domestic IL GS Deliveries 
/ M IL Adult Pop. 
52 / 5.33 = 9.81 
Domestic GS Infants Adult Score An. Av. GS Infants born in IL / M 
IL Adult Pop. 
64 / 5.3 = 12.08 
 
In order to assess the significance of the resulting scores, we will juxtapose them with 
comparable US figures, which we now turn to calculate.  
The USA 
Between the years 1999 and 2013, 30,927 gestational carrier cycles (GCC) were carried out in 
the USA, resulting in the birth of 18,400 infants in 13,380 deliveries, i.e., 1.38 infants per 
delivery. Most GS infants (53.4%; n=9,819) were born in multiple birth [36]. Both the absolute 
number and the percentage of GCC out of all ART cycles rose significantly during this period, 
from 1% (n=727) in 1999 to 2.5% (n=3,432) in 2013 [36]. Between the years 2004 and 2008, the 
number of infants born to GS in the US almost doubled, rising from 738 to nearly 1,400 [24].  In 
the subsequent years, between 2010 and 2014, 16,148 GCC were performed in the USA, 
resulting in the birth of 10,009 live infants [38]. Given 30.7% (n = 2,341) of multiple live births 
 
1 Rounded figures are used for clarity 
2 [50]. The exact figure for July 2012, the middle point, is 7,916,600 
3 [51] The exact figure for age 18 and over, July 2013, the middle point, is 5,316,298 
in this period [38], the number of deliveries amounts to 7,6454, i.e., 47.34% of all GCC. Of these 
cycles, 17.68 % (N=2,852) were taken up by foreign (non-USA) residents [37] leaving 13,296 
GCC carried out by USA resident IP. These figures are summarized in Table 3. 
 
Table 3: USA GCC Figures (2010-2014)  
 from [38] 
 Total USA resident IP Foreign (non-USA) 
resident  IP 
Year 2010-2014      N An. Average      N An. Average       N Ann. Average 
GCC  16,148 3,230 13,296 2,659    2,8525 570 
Deliveries    7,645   1,529 6,292 1,258 1,353 271 
Infants  10,009   2,002 8,237 1,647 1,772 354 
 
Before turning to the score calculation, we should remind, once again, that the following 
calculations apply only to those GS performed in the USA and as such, is but a partial estimation 
of GS cycles conducted by US citizens. Whereas the percentage of non-USA resident IP that are 
included in the data is known and can be analysed, the scope of CBS conducted by USA resident 
IP is unknown. Table 4 presents the proportion of deliveries and infants vis-à-vis the general 
American population and the American adult population.  
 
Table 4: USA GS Delivery and Infant Scores (2010-2014) 
Authors’ calculations 
 
USA Score 
(Total: USA and non-USA resident IP) 
Score Description 
 
Score Value 
Domestic GS Delivery Score An. Av. Total Domestic USA 
GS Deliveries / M USA Pop. 
1,529 / 3146 = 4.87 
Domestic GS Infants Score  An. Av. Total GS Infants born in 
the USA / M USA Pop. 
2,002 / 314 = 6.38  
Domestic GS Delivery Adult Score An. Av. Total Domestic USA 
GS Deliveries / M USA Adult 
Pop. 
1,529 / 2397 = 6.40 
Domestic GS Infants Adult Score  An. Av. Total GS Infants born in 
the USA / M USA Adult Pop. 
2,002 / 239 = 8.38  
 
Rather similar to the Israeli field, the US figures disclose a high rate of multiple birth, that has 
indeed been somewhat reduced in recent years but remains at the relatively high level of 1.38 
 
4 Number of deliveries calculation: 2,341:0.307 = 7,645 
      deliveries  infants 
Singletons 7,645 - 2,341 = 5,313   5,313 
Twins +           2,341 x 2        4,682+  
Total      9,995+   possibly 14 triplets: 9,995+ 14 = 10,009). 
5 [38]. Table 1, column 7. 
6 [52] The exact figure is 313,914,040 
7 [52] The exact figure is 238, 574,670 
baby per delivery. We now move on to compare the two datasets in order to gain an insight into 
the relative incidence of local GS practice vs the surrounding population. 
 
Comparative Assessment: Gestational Surrogacy in Israel and the USA  
We approach our comparison by looking at the rate of multiple births in the local GS practice of 
each country during the scrutinized years: 2010-2014. In Israel's domestic practice, multiple 
births comprised 24% [(321-259) / 259] of GS deliveries (assuming that multiple births consist 
only of twins), lower than the US respective figure of 30.7%8. In line with these figures, Israel's 
average of Baby / Delivery stood on 1.24 vs 1.38 in the USA. What is the meaning of these 
figures in their nationwide contexts? What are the implications for local women who engage in 
GS in the USA and Israel? Since the Israeli data does not monitor GS cycles but only deliveries 
and newborn infants, our comparison assesses these variables. Table 5 summarizes the resulting 
comparative scores. 
 
Table 5:  GS in the USA vs. Israel: Comparative Deliveries and Infant Scores*  
 
  USA Israel Israel / USA 
 Proportion of Surrogacy  
1.  Percentage of All IP GS Deliveries / All 
Domestic Deliveries 
1,529 / 3,952,8419= 
0.39‰ 
52 / 163,72510 = 
0.32‰ 
0.82 
2.  Percentage of Local IP GS Deliveries (USA 
resident IP / All Domestic Deliveries 
1,258 / 3,952,84111 
= 
0.318252‰ 
52 / 163,72512 = 
0.317606‰ 
0.997 
  
Score (Score Description) 
All Domestic GS: USA and non-USA 
resident IP 
 
3.  Domestic GS Infants Score (An. Av. GS 
Infants born / M Pop.) 
2,002 / 314 = 6.38 64 / 7.9 =   8.1 1.27 
4.  Domestic GS Delivery Score (An. Av. 
Domestic GS Deliveries / M Pop.) 
1,529 / 314 = 4.87 52 / 7.9 = 6.58 1.35 
5.  Domestic GS Infants Adult Score (An. Av. 
GS Infants born / M Adult Pop.) 
2,002 / 239 = 8.38 64 / 5.3 = 12.08 1.44 
6.  Domestic GS Delivery Adult Score (An. Av. 
Domestic GS Deliveries / M Adult Pop.) 
1,529 / 239 = 6.40 52 / 5.3 = 9.81 1.53 
 Score (Score Description) 
USA resident IP vs. Israeli IP 
 
 
8 The multiple birth percentage declines in the course of the years from 53.4% [37] in 1999-2013 to 30.7% [38] in 
2010-2014. 
9 In [45] 
10 2012 figures: 170,940 (Live birth) + 585 (still births) – 7,800 (multiple births) = 163,725 
https://www.cbs.gov.il/he/publications/DocLib/2018/3.%20ShnatonVitalStatistics/st03_01.pdf and [46].  
11 In [45] 
12 2012 figures: 170,940 (Live birth) + 585 (still births) – 7,800 (multiple births) = 163,725 
https://www.cbs.gov.il/he/publications/DocLib/2018/3.%20ShnatonVitalStatistics/st03_01.pdf and [46].  
7.  Domestic Am. IP GS Infants Score (An. Av. 
GS Infants born to USA resident IP / M Pop.) 
1,647 / 314 = 5.25 64 / 7.9 =   8.1 1.54 
8.  Domestic Am. IP GS Delivery Score (An. Av. 
Domestic GS Deliveries to USA resident IP/M 
Pop.) 
1,258 / 314 = 4.00 52 / 7.9 = 6.58 1.64 
9.  Domestic Am. IP GS Infants Adult Score (An. 
Av. GS Infants born to USA resident IP / M 
Adult Pop.) 
1,647 / 239 = 6.89 64 / 5.3 = 12.08 1.75 
10.  Domestic Am. IP GS Delivery Adult Score 
(An. Av. Domestic GS Deliveries to USA 
resident IP / M Adult Pop.) 
1,258 / 239 = 5.26 52 / 5.3 = 9.81 1.86 
 Fertility rates  
11.  Birth rate (births per 1,000 population) 12.613 per 1,000 
population 
21.614 per 1,000 
population 
1.714 
12.  General fertility rate (number of live births per 
1,000 women of reproductive age) 
53.615 per 1,000 
women of 
reproductive age 
91.416 per 1,000 
women of 
reproductive age 
1.705 
13.  Total fertility rate (total number of children 
born or likely to be born to a woman in her life 
time if she were subject to the prevailing rate 
of age-specific fertility in the population) 
1,880.517per 1,000 
women 
3,05018 per 
1,000 women 
1.621 
*Extrapolated from tables 1-4 above and cited sources. 
 
The table's first row demonstrates that in the US, GS deliveries comprised 0.39‰ of all local 
deliveries during the scrutinized period, whereas in Israel, such deliveries comprised, in the same 
period, a smaller fraction: 0.32‰ all local births. This may suggest that Israelis opt for surrogacy 
as the pathway to family formation less frequently than their American counterparts. Practically 
all of this difference vanishes, however, if we set aside foreign (non-American) IP. If we look at 
USA resident IP, both heterosexual and gay, as compared to Israeli IP (row 2), then the 
proportion of GS deliveries as part of all domestic deliveries is 0.997, i.e. practically identical. At 
first glance, this similarity may appear to represent equal respective use of GS by local IP. 
Aspiring for a finer understanding, we delve deeper into the figures. The equal ratio shows that 
in both the USA and Israel the use of surrogacy as reproductive method is alike. However, we 
need to bear in mind that Israeli IP of domestic GS are only heterosexual couples and single 
women, whereas in the USA, persons of all sexual orientations are allowed to contract a 
gestational surrogate. The resulting similarity therefore most likely encapsulates higher overall 
use of GS by Israeli IP. 
A supplementary approach to evaluate the relative weight of GS on women in each country, is to 
weigh GS deliveries and infants, vis-à-vis the respective local populations. Considered from this 
 
13 Table 10 [53]  
14 Table 10 [53]  
15 Table 10 [53]  
16 Table 10 [53]  
17 Table 4 [54] 
18 Table 4 [54] 
perspective, Israel's GS practice emerges as highly intense. As shown in rows 3-6 of Table 5, 
relatively speaking, more Israeli women and more IP are engaged in GS than their US 
counterparts. The same is true for the resulting children: In relation to the relevant local 
population, more GS children are being born in Israel than in the US (6.38 / 8.1 = 1.27). 
However, as the Baby / Delivery Score is higher in the US than in Israel, the discrepancy further 
increases when we turn to look at the delivery scores proportions which stands on 1.35. When we 
refine our assessment by looking at the respective adult populations, in order to account for the 
inter-country difference in fertility rate, the gap further widens, to roughly 2:3 (1.53). These 
figures mean that in the years 2010-2014, the load of surrogacy in proportion to the general and 
adult population was 53% higher on Israeli women as compared to USA women, i.e., for every 2 
American women who were engaged in GS, there were 3 Israeli women engaged likewise. When 
we adopt an IP perspective and set aside non-USA resident IP, the gap evidently widens still 
further. Removing foreign IP who contract American gestational surrogates, the inter-country 
discrepancies increase to 1.54-1.86 (rows 7-10). 
Local birth rates and fertility rates, indicating an inter-country proportion of 1.62 to 1.71 (rows 
11-13) seem to be key to understanding the emerging gaps in GS incidence.  
 
DISCUSSION AND CONCLUSION 
The quantitative analysis presented above, of the incidence of GS in the USA and Israel, shows 
an expansion of the practice in both settings. More specifically, though GS infants comprised a 
slightly higher percentage of US infants than the respective percentage in Israel, in the years 
2010-2014, the incidence of GS per local population was roughly 50% higher in Israel than in 
the US. Israeli adult women thus have an increased likelihood of being engaged in GS than 
American adult women. Considered from IP perspective, this gap is all the more instructive, as it 
rises to 1.86, when we compare each country's GS Deliveries initiated by the country's local IP in 
proportion to the local Adult population. In other words, there were nearly twice as many GS 
deliveries to Israeli IP in Israel than to USA resident IP in the USA. 
The gap is especially instructive given the scope of each country's potential PI clientele. As 
mentioned, in the US, gestational surrogates are contracted by multiple IP categories: 
heterosexual and gay, partnered and single, local and international. In Israel, in contradistinction, 
only local heterosexual couples and single women are eligible to domestic GS. Israeli gay men 
and international IP may not initiate such contracts. And yet, as shown, the relative incidence of 
GS is substantially higher than in the US.  
We suggest that the incidence gap echoes the respective gap in fertility rates, i.e., that the higher 
incidence of GS in Israel reflects the country's higher fertility rates, which exceeds those of all 
other industrializes countries. The number of newborn infants per year is 60-70% higher in Israel 
as compared to the respective figures in the USA (rows 11-13, Table 5). When considered 
against the respective local fertility rates, it may appear that in both countries, IP are as keen to 
found families as their counterparts who do not need to use gestational surrogates. On a second 
look, however, the gap widens, because, as mentioned, Israeli GS serve a much smaller category 
of IP. (Indeed, USA resident IP also opt for CBS. However, as the option to conduct GS 
domestically is available to all, it seems reasonable that the proportion is not as high. US specific 
data, showing substantial inter-state GS travel [38] supports this hypothesis.) This quantitative 
demonstration of the higher relative incidence of GS in Israel, evidently coheres with qualitative 
studies that showed GS to be culturally embedded in its broader context (e.g. [14], [17]). 
What can we learn about and from these relatively well-regulated arenas of GS practice? What 
are the implications of the resulting scores on women's health? We should first draw attention to 
the women left outside the present analysis. As mentioned, the statistics presented above refer 
only to those GS who have had a live birth. As the Israeli report does not mention cycle numbers, 
we could compare only deliveries and live births. An Israeli MoH officer informally estimated 
that the delivery rate of GS is roughly 25-35%, as common in Israel's IVF practice. The US 
figures that count numbers of GS cycles, represent 47.34% of delivery per GS cycles [38]. 
However, even the US reports exclude those gestational surrogates who have not reached the 
embryo transfer phase. These inclusion criteria leave out numerous women who have all 
collected legal forms and issued medical records, who have gone through medical tests and 
psychological assessments and eventually, having been approved for the task, have been matched 
to specific IP, has undergone the clinical preparation for embryo transfer, including repeated 
clinic visits and intake of medications, most likely, in several cycles of unsuccessful treatment. 
These women will be paid but a minimal compensation that at best will cover their own GS 
related expenses. The USA Delivery / Cycle figures and the Israeli estimates are a crucial 
reminder that the number of women engaged in GS is substantially higher than depicted above. 
In fact, they strongly suggest most women who engage in surrogacy do not receive the main 
payment and often go unreported.  
Women, who do conceive and have a live birth, are likely to face other concerns. As shown 
above, the percentage of multiple births is exceptionally high in GS pregnancies. In the general 
USA delivery reports, twin births comprise 3.3% of all births nationwide, and higher-order births 
account for another 0.12% [45]. Among USA GS, multiple live births accounted for 30.7% of all 
live births [38]. Even when compared to women undergoing fertility treatments, GS are more 
likely to carry multiple pregnancy. (The incidence of having more than one embryo transferred 
in a treatment cycle in the USA is 60.4% vs 54.6% respectively [36]). In Israel, in the year 2012, 
halfway through the scrutinized period, 4.4% of all infants were twins; 4.6% of the infants were 
born in multiple births [46]. In comparison, of 321 domestic GS infants born in Israel in the 
scrutinized period, roughly 124 (62x2) infants were born in multiple births, amounting to 39%19  
of GS infants in the period. The differences are self-evident and momentous.  
In terms of women's health (the health of the GS infants is beyond the present discussion), the 
elevated percentage of multiple pregnancies means that gestational surrogates face greater health 
risks than that most non-GS pregnant women. According to the American College of 
Obstetricians and Gynecologists, women who carry multiple pregnancy have increased risk of 
various pregnancy-related conditions, like preeclampsia, gestational diabetes, preterm birth, 
cesarean birth as well as postpartum depression [47]. Additional heightened risks include 
gestational hypertension, anemia, miscarriage and postpartum hemorrhage [48]. Some of these 
 
19 (321-259) X 2/321= 0.39; For the sake of clarity, we assumed that all multiple births were 
twins. 
conditions may have long term effects, like increased risk for diabetes mellitus, chronic 
hypertension, cardiovascular diseases, coronary heart disease and stroke [49]. To the best of our 
knowledge, gestational surrogates are normally not covered nor are they compensated for such 
long-term health consequences. 
To sum up, more and more women and men in the USA and Israel are opting for GS in order to 
found families; more and more American and Israeli women engage in GS. These women expose 
themselves to two related risk. The first is the risk of not conceiving and delivering a live infant, 
which results in great effort to become a surrogate without reception of the monetary 
compensation and emotional recognition. The other risk, which faces those GS who do deliver, is 
that of multiple pregnancy and birth, with their increased risk to various immediate and long 
term health conditions.  
This reality needs to be borne in mind when considering surrogacy related issues that affect the 
scope of the practice and the wellbeing of the participating women. They should also be recalled 
vis-à-vis media presentations that often focus on the pain of intended parents and the happy 
endings of successful GS births. Whereas the desire to have a family, as well as the bliss of GS 
births and the personal closeness that evolve between some surrogates and IP should be well 
acknowledged and certainly must not be underestimated, it is equally crucial, when making 
policy, financial and clinical decisions, to bring forward the tremendous investment of time, 
money, emotion and bodily resources on the part of women who engage in gestational 
surrogates. 
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